0001181431-13-015382.txt : 20130307
0001181431-13-015382.hdr.sgml : 20130307
20130307165131
ACCESSION NUMBER: 0001181431-13-015382
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130305
FILED AS OF DATE: 20130307
DATE AS OF CHANGE: 20130307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gionco David
CENTRAL INDEX KEY: 0001456864
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15313
FILM NUMBER: 13674016
MAIL ADDRESS:
STREET 1: 9 HOWELL DRIVE
CITY: FAR HILLS
STATE: NJ
ZIP: 07931
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd373245.xml
GIONCO FORM 4
X0306
4
2013-03-05
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001456864
Gionco David
SAVIENT PHARMACEUTICALS, INC.
400 CROSSING BLVD 3RD FLOOR
BRIDGEWATER
NJ
08807
0
1
0
0
Group VP & Chief Acct. Officer
Common Stock
2013-03-05
4
A
0
29000
0.00
A
85200
D
These shares of restricted stock will vest in proportional 1/3 increments on each of the first three anniversaries of the grant date, March 5, 2013.
Philip K. Yachmetz as attorney-in-fact for David Gionco
2013-03-07